Brief: Xspray Pharma Signs License Agreement With Handa Therapeutics

Xspray Pharma publ AB

12/08/2025 07:20

Aug 12 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST:

XSPRAY PHARMA SIGNS LICENSE AGREEMENT WITH HANDA THERAPEUTICS – TO RECEIVE UP TO DOUBLE-DIGIT ROYALTY ON HANDA’S NET PROCEEDS

LICENSE COVERS DASATINIB IN US AND ASIAN MARKETS

Source text: ID:nMFN57XPyR

Further company coverage: XSPRAY.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))